This inventor holds 1 USPTO granted patent. Top assignees: Massachusetts Institute of Technology, Nova Pharmaceutical Corporation. Active years: 1992.
Company Filing History:
1 out of 8,573 
1 out of 23 Years Active: 1992
Title: The Innovations of Tom Turek
Introduction
Tom Turek is an accomplished inventor based in Dorchester, MA (US). He is known for his significant contributions to the field of biomedical engineering, particularly in the development of controlled release devices for biologically active substances. His innovative work has led to the creation of a patent that addresses the challenges of administering growth hormone proteins effectively.
Latest Patents
Tom Turek holds a patent for "Polyanhydride bioerodible controlled release implants for administration." This invention is a controlled release device designed for the administration of biologically active growth hormone proteins or peptide fragments. The method of preparation involves stabilizing the biologically active growth hormone and modulating the release rate by incorporating a stabilizing compound. The devices are created by mixing a stabilizer, such as sucrose, with the growth hormone in solution, lyophilizing the mixture, and then incorporating the dried powder into a biocompatible polymeric matrix.
Career Highlights
Throughout his career, Tom Turek has worked with prestigious organizations, including the Massachusetts Institute of Technology and Nova Pharmaceutical Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Tom Turek has collaborated with notable individuals such as Eyal S Ron and Mark Chasin. These partnerships have further enhanced his work and expanded the impact of his inventions in the biomedical field.
Conclusion
Tom Turek's innovative contributions to controlled release technology demonstrate his commitment to advancing biomedical engineering. His patent and collaborations reflect his expertise and dedication to improving the administration of biologically active substances.